Global Peptide Synthesis Market By Product Type(Equipment, Reagents & Consumables, Other Product Types) By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) By Application-Therapeutics(Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) By Diagnosis, By Research, By End-use (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization/Contract Research Organization, Academic & Research Institutes) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033
- Published date: Feb 2024
- Report ID: 18814
- Number of Pages: 393
- Format:
-
-
-
- Lonza Group AG Company Profile
- MP Biomedicals
- Novo Nordisk A/S.
- Genscript Biotech
- CEM Corporation
- Thermo Fisher Scientific Company Profile
- Creative Diagnostics
- Polypeptide Group
- Syngene, PuroSynth
- Merck KGaA Company Profile
- Bachem Holdings
- Biotage
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible